Clinical Trials Directory

Trials / Completed

CompletedNCT02857751

Evaluation of Outcomes Following Surf Therapy

Evaluation of Health Outcomes Following the NMCSD Surf Therapy Program

Status
Completed
Phase
Study type
Observational
Enrollment
75 (actual)
Sponsor
United States Naval Medical Center, San Diego · Federal
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The current study evaluates psychological and physical health outcomes for active-duty service members following participation in an established surf therapy program. Participants complete assessments before and after the surf therapy program, as well as brief assessments before and after each surf therapy session.

Detailed description

The proposed study would evaluate whether an existing surf therapy program that is part of the Wounded, Ill, and Injured (WII) Wellness Program at Naval Medical Center San Diego (NMCSD), significantly reduces both psychological symptoms (e.g., PTSD, depression, anxiety, negative affect, lack of positive affect) and physical symptoms (e.g., pain, sleep) among active-duty service members. Psychological and physical symptoms will be assessed before beginning the surf program and at program completion. In addition, brief assessments of mood and symptoms will be completed before and after each individual surf therapy session.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSurf therapyThe NMCSD surf therapy program is approximately 6 weeks in duration. Each surf therapy session lasts 2-3 hours and occurs in a group setting that can accommodate up to 20 service members per session. Each service member is paired with a surf instructor who works with him or her each week for the 6-week session. Goals are individually-tailored to the service member (based on participant's level of comfort in the water, experience with surfing, etc.) and can incorporate both physical and psychological objectives.

Timeline

Start date
2016-06-01
Primary completion
2017-12-15
Completion
2018-12-31
First posted
2016-08-05
Last updated
2021-09-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02857751. Inclusion in this directory is not an endorsement.